Semaglutide and Tirzepatide: Improving Outcomes for Heart Failure Patients
A new study published in JAMA offers encouraging insights for people living with heart failure with preserved ejection fraction (HFpEF),
Diabetes, Diseases and Conditions, Endocrine and Metabolic Diseases, Heart and Cardiovascular Diseases, Medical Health